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Alain Depierre, MD, Jean-Charles Dalphin, MD, and Patrick Arveux, MD
Introduction: Several studies have suggested that rurality is a risk
factor for worse prognosis in cancer.
Methods: The study population included the 2268 lung cancer cases
collected between 1981 and 1996 in the Doubs Cancer Registry
(France).
Results: The numbers of patients were 849 (31.8%) in rural areas
and 89 (3.3%) in very rural areas. The relative 5-year survival was
15.2% in rural areas and 13.4% in urban areas (p  0.5), and 2.7%
in very rural areas and 14.4% in extended urban areas (p  0.02).
Multivariate analyses of observed and relative survival showed that
patients living in very rural areas (p  0.0001), 65 years of age and
older and having small cell carcinoma had a significantly shorter
survival.
Conclusions: This study showed that the multidimensional defini-
tion of rurality identified a population with unfavorable prognoses.
Key Words: Lung cancer, Rural, Survival, Cancer registry, Prog-
nostic factors.
(J Thorac Oncol. 2007;2: 613–618)
Lung cancer is a leading cause of cancer mortality in alldeveloped countries. Lung cancer incidence is high, even
still increasing in many countries such as France, with 22,000
new cases every year for a Europe-standardized incidence
rate of 35%.1 The disease remains fatal in a majority of cases,
and mortality rates very close to incidence rates are observed.
Only modest improvement in prognosis has been demon-
strated over the past 20 years, due to therapeutic advances but
also to a greater use of cancer treatments.2–4
In developed countries, it is of high priority for health
care policies to provide everyone with optimal care. There-
fore, it is of utmost importance to identify patients with
poorer survival and to evaluate the magnitude of the survival
difference. Because rural patients might be, for many reasons,
at a greater distance from health care services, they constitute
a population at risk of poorer prognosis. Several studies
focusing on lung cancer have used the distance to the nearest
cancer treatment center as the definition of rurality.5–9 Only
one of these studies analyzed survival and showed that
patients from outlying areas had poorer survival.5 Simplicity
is the main advantage of this definition. However, only one
component of the multidimensional concept of rurality is
taken into account. Besides being usually remote from spe-
cialized health centers, rural areas also have economic and
sociological characteristics. A particular psychological pro-
file was also reported in rural population: rural patients
seemed to have less demanding expectations of their care.10
Therefore, distance may not be the most relevant definition of
rurality for every geographic area. Despite the large size of a
Canadian province such as British Columbia, a study con-
ducted in the 614 patients included in its registry for a small
cell lung cancer (SCLC) in 1990 and 1995 showed no
survival difference between patients living within a 2-hour
drive from one of the regional cancer centers and those living
more than 2 hours to a cancer center.11 Therefore, this study
was performed to test the impact of two other definitions of
rurality on survival inequalities in lung cancer. The first
definition consisted of a common and simple approach of
rurality, based on population density, and the second one
offered a multidimensional evaluation of rurality.
MATERIALS AND METHODS
Study Population
The study population included all incident cases of
primary lung cancer between January 1, 1981 and December
31, 1996 in the Doubs department. Data were obtained from
the Doubs Cancer Registry database. The Doubs is one of the
96 French metropolitan departments. It is located in eastern
France and has a surface area of 5234 km2. All public or
private pathological laboratories of the Doubs department
systematically send to the registry copies of all histology
reports of newly confirmed cancer cases. Data are checked
against death certificates and lists of new cancer cases from
physicians at public and private institutions. Information
collected by the registry includes demographic characteristics
(gender, age, residence at the time of diagnosis), date of
pathological diagnosis, pathology, and site of cancer within
the lung according to the International Classification of Dis-
eases for Oncology (ICD-O), second edition.12 Patients who
were diagnosed at autopsy were excluded from this analysis.
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In patients in whom metachronous lung cancers were diag-
nosed, only the first case was kept. Histology was categorized
into five groups using ICD-O codes: small cell (8021, 8041,
8042, 8043, 8044), squamous cell (8033, 8052, 8070, 8071,
8072, 8074), adenocarcinoma (8050, 8140, 8141, 8190, 8201,
8211, 8250, 8251, 8260, 8310, 8480, 8481, 8550), other
carcinoma and carcinoma not otherwise specified (8000,
8010, 8012, 8020, 8030, 8031, 8200, 8240, 8246, 8560), and
without pathological confirmation (9990).
Main Independent Variables: Rurality
Two variables were constructed to study rurality, using
the two official definitions of the French National Institute of
Statistics and of Economics Studies and data of the French
1990 census.13 The residence of patients was the community
where patients lived at the date of pathological diagnosis:
Variable 1: Rural versus urban areas. Subjects were defined
as rural residents if they were not living in a built-up area
(housing not more than 200 meters apart) of more than 2000
inhabitants. Other patients were considered as coming from
urban areas. Variable 2: Very rural versus extended urban
areas. Very rural and extended urban areas were identified by
taking into account not only the population density, but also
the commercial, industrial, and administrative activities of the
community of residence, the proportion of residents working
outside the community, the proportion of households living
on agriculture and the demographic increase. When the res-
idence was located outside an extended urban area, a patient
was considered to be resident of a very rural area. Extended
urban areas included not only urban communities, as defined
by variable 1, but also communities of fewer than 2000
inhabitants but with one or more of the following conditions:
more than 100 employees, proportion of the population work-
ing outside the community more than 1.2  proportion of
households living on agriculture, population increase be-
tween 1975 and 1982 more than (1.09  proportion of
households living on agriculture)  (0.9  proportion of the
population working outside the community).
Additional Independent Variables
Other variables included in the analysis were gender,
age, period of diagnosis, pathology, and mean annual income.
Age was dichotomized using the median age of the cohort.
The period of diagnosis used two 8-year periods, 1981 to
1988 and 1989 to 1996. Pathology was analyzed as SCLC
and non-small cell lung cancer (NSCLC). NSCLC included
squamous cell carcinoma, adenocarcinoma, other carcinoma,
carcinoma not otherwise specified, and carcinoma without
pathological confirmation. Cases were assigned the mean net
annual income of all taxable and nontaxable households in
their community of residence. This socio-economic variable
was based on the 1990 census and was expressed for each
subject as the ratio of the annual income in the community to
the mean annual income for all the communities in the cohort.
This variable was dichotomized using a 15% variation from
the mean value of the cohort.
As we used data from the Doubs Cancer Registry
database, we did not have information about stage, perfor-
mance status, and therapy. Retrospectively, we only had these
data for our own patients (from the Chest Disease Department
of the Besanc¸on University Hospital).
Statistics
Age-standardized (world standard population14) inci-
dence rates were calculated for the period 1981 to 1983 using
data from the 1982 census and for the period 1984 to 1996
using data from the 1990 census. The Doubs department had
a population of 236,144 men and 241,527 women in 1982 and
of 236,967 men and 254,861 women in 1990.15
Correlation between independent variables was system-
atically investigated by the 2 test. For survival analysis, the
endpoint date was July 16, 2001. Beyond 5 years, data were
censored. Probability of observed survival (S[t]) was esti-
mated using the actuarial method and univariate survival
comparisons were performed by the log rank test. Relative
survival was calculated using the French mortality tables for
the period 1988 to 1990.16 Univariate comparisons of relative
survival used the test of the maximum of likelihood.17
Two different Cox models were generated to analyze
observed survival. The Cox regression model 1 included
rurality variable 1, and, among the other independent vari-
ables, those correlated with survival with a p value of less
than 0.20 in the univariate analyses of both observed and
relative survival. Rurality variable 2 and all other indepen-
dent variables correlated with survival with a p value of less
than 0.20 in the univariate analyses of both observed and
relative survival were entered in the Cox model 2. The risk
proportionality was checked by the graphic representation of
ln(ln[S(t)]) over time. In case of nonproportionality of risks,
an interaction variable with time was introduced in the model
as a time-dependent variable. A multivariate analysis of
relative survival was undertaken to assess the effect of the
rurality variable that had the most significant prognostic value
in the model of observed survival.18 The regression model by
Hakulinen and Tenkanen18 was used and the same variables
kept for the multivariate analysis of observed survival were
included. A p value of less than 0.05 was considered as
statistically significant. Univariate and observed survival
analyses were performed using the SAS software.19 Relative
survival rates were computed with the program by Hakulinen.
RESULTS
Study Population
Between 1981 and 1996, 2690 cases of primary lung
cancer were registered in the Doubs Cancer Registry. Fifteen
cases diagnosed at autopsy were excluded from the study.
The 2675 remaining cases occurred in 2668 patients. World-
standardized incidence rates increased in men from 49.9 per
100,000 in 1981 to 58.2 per 100,000 in 1996, and in women
from 2.9 per 100,000 in 1981 to 7.6 per 100,000 in 1996. The
2668 first cases were kept for analysis. In 1990, among the
484,770 inhabitants of the Doubs department, 163,488
(33.7%) were living in rural areas (rurality variable 1) and
15,744 (3.3%) in very rural areas (rurality variable 2). Among
the 2668 patients, 849 (31.8%) were living in rural areas and
89 (3.3%) in very rural areas. The median age at diagnosis
was 64 years (range, 22–94 years). The estimated mean
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annual income of the 2668 subjects was 12,685 Euros (SD 
1828). Characteristics of the 2668 patients and of their first
lung cancer are detailed according to the rurality variables in
Table 1. Gender, age, period of diagnosis, and histology did not
differ between rural and urban patients or between very rural
areas and extended urban areas. The mean annual income was
significantly lower in rural and in very rural patients, with a
larger difference between patients from very rural areas and
extended urban areas than between rural and urban patients.
In the subgroup of 1816 patients from our hospital, 49
were living in very rural areas and 1767 in extended urban
areas Therefore, the proportion of patients living in very rural
areas was lower in this subgroup (2.7%) than in the subgroup
of patients who never came to our department (4.7%). Pa-
tients living in very rural areas were less often referred to our
hospital: 55% (49/91) versus 68% (1767/2579). However, in
our hospital subgroup, age, sex, performance status, standard-
ized cancer treatment (versus best supportive care only),
histology, and presence (or absence) of metastases did not
differ between patients from very rural areas and extended
urban areas.
Survival
As of July 16, 2001, 155 patients (5.8%) were still
alive, 2494 (93.5%) had died, and 19 (0.7%) were lost to
follow-up. Observed survival of the whole population was
43.4% (SE  0.010) at 1 year, 24% (SE  0.008) at 2 years,
16.9% (SE  0.007) at 3 years, 11.8% (SE  0.006) at 5
years, and 6.8% (SE  0.5) at 10 years. Overall relative
survival of the cohort was 44.6% (SE  0.010) at 1 year,
25.5% (SE  0.009) at 2 years, 18.6% (SE  0.008) at 3
years, and 14% (SE  0.007) at 5 years.
Univariate analyses of observed and relative survival
are detailed in Table 2. Both observed and relative survival
analyses showed that patients living in very rural areas
(rurality variable 2), and/or aged 65 years or older and/or who
had a small cell type of carcinoma had a significantly shorter
survival (p  0.05). There was no survival difference be-
tween patients coming from rural areas and those living in an
urban environment (rurality variable 1). Correlation of mean
annual income and survival was significant for observed
survival (p  0.01) but was of borderline significance for
relative survival (p  0.05).
Rurality variable 1, age, period of diagnosis, pathology,
and mean annual income were entered in the Cox regression
model 1. Rurality variable 2, age, period of diagnosis, pathology,
and mean annual income were entered in the Cox regression
model 2. As risks were not proportional over time for the
pathology variable, a pathology x time interaction was intro-
duced in the Cox models. Variables of unfavorable significance
on observed survival in the multivariate analysis were very rural
residence (rurality variable 2), age of 65 years or older, and
SCLC (Table 3). The same variables were shown to be associ-
ated with decreased survival in the multivariate analysis of
relative survival. There was a trend for improved prognosis of
lung cancer over time and in patients with a higher mean annual
income. If mean annual income was omitted in the multivariate
analysis because of its correlation with rurality variable 2, very
rural areas remained highly correlated with survival with a
TABLE 1. Characteristics of Patients Diagnosed with Primary Lung Cancer in the Doubs Department from 1981 to 1996
According to the Rurality Variables
Rurality Variable 1 Rurality Variable 2
Characteristics Rural, No. (%) Urban, No. (%) p Very Rural, No. (%) Extended Urban, No. (%) p Total (%)
Gender 0.10 0.39
Male 761 (90) 1590 (87) 81 (91) 2270 (88) 2351 (88)
Female 88 (10) 229 (13) 8 (9) 309 (12) 317 (12)
Age, yr 0.50 0.74
65 435 (51) 901 (50) 43 (48) 1292 (50) 1335 (50)
65 414 (49) 918 (50) 46 (52) 1287 (50) 1333 (50)
Period of diagnosis 0.52 0.82
1981–1988 365 (43) 806 (44) 38 (43) 1133 (44) 1171 (44)
1989–1996 484 (57) 1013 (56) 51 (57) 1446 (56) 1497 (56)
Pathology 0.12 0.66
Small cell 135 (16) 267 (15) 14 (16) 388 (15) 402 (15)
Squamous cell 473 (56) 982 (54) 48 (54) 1407 (55) 1455 (55)
Adenocarcinoma 156 (18) 329 (18) 14 (16) 471 (18) 485 (18)
Other and NOS 71 (8) 214 (12) 10 (11) 275 (11) 285 (11)
Not histologically verified 14 (2) 27 (1) 3 (3) 38 (1) 41 (1)
Mean incomea 104 104
85% 164 (20) 243 (13) 53 (73) 354 (14) 405 (15)
85% 659 (80) 1576 (87) 20 (27) 2215 (86) 2235 (85)
Total 849 (32) 1819 (68) 89 (3) 2579 (97) 2668
NOS, not otherwise specified.
a Missing data for 17 communities corresponding to 26 patients.
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hazard ratio of 1.4 (95% confidence interval [CI]: 1.1–1.7; p 
0.004) for observed survival and 1.4 (95% CI: 1.1–1.8; p 
0.004) for relative survival.
DISCUSSION
Both the observed and relative survival analyses of this
study showed that the 3.3% of patients living in very rural
areas had a risk of death 1.3 times higher than that of subjects
from extended urban areas. Using a definition of rurality only
based on population density, there was no survival difference
in survival between rural and urban residents. Other factors of
significant unfavorable prognosis were age of 65 years or
older and small cell type. A trend for improved survival was
also observed in the 1990s.
The major difficulty when analyzing the influence of
rurality on survival is the definition used to distinguish rural
from urban areas. In most studies, rurality was estimated by
the distance to the nearest treatment center.5–8 The definition
of very rural areas and of extended urban areas, which took
into account not only population density but also industries,
commuting rates, proportions of households living from ag-
riculture and the demographic increase, offered a better
identification of economically isolated populations. These
areas also corresponded to deprived areas, which were re-
ported to be associated with decreased cancer survival rates
and a significant reduction in chemotherapy delivery (odds
ratio  0.39, 95% CI: 0.16–0.96, p  0.028).7,20 In the
multivariate analysis of our study, very rural residence had a
prognostic implication independently of deprivation. Because
this very restrictive definition of rurality concerned a small
proportion of the department population, only 3.3% of the
2668 registered cases were in the very rural category. How-
ever, considering the high incidence rates of lung cancer and
the 11.7% survival difference at 5 years between patients
from very rural areas and from extended urban areas, the rate
of 3.3% may be worth being identified as well as the reasons
for this worse prognosis.
Because very rural areas were also shown to contribute
to an unfavorable prognosis in the analysis of relative sur-
vival, deaths should be related to the lung cancer. Hypotheses
to explain this poorer survival rate of patients living in very
rural areas include more advanced disease at the time of
diagnosis and at the beginning of treatment and differences in
treatments. However, in the subgroup of patients from our
department, we did not find any difference for presence of
metastases or in the proportion of patients having received
standardized cancer treatment between patients living in very
rural areas and those living in extended urban areas. Data on
tumor stage were not available for this study. Extension of
cancer is one of the most powerful prognostic factors of lung
cancer.4,21 Three studies have demonstrated that patients
living in remote areas had more advanced lung cancers.6,8,9
One study was conducted in all cases of colorectal and lung
cancer from north and northeast Scotland and collected by the
Scottish Cancer Registry in 1995 and 1996.6 Definition cri-
teria for rural areas used the straight line distance between
patients’ residence and the nearest cancer center. Proportions
of disseminated lung cancers were 42% among the 164
subjects living further than 57 km from the nearest cancer
center, 34% in the 143 patients living between 38 and 57 km
from the cancer center, and 33% in the 314 patients living
within 37 km (p  0.25; p value for linear trend  0.098).
TABLE 2. Univariate Analyses of Observed and Relative Survival
5-yr Observed
Survival
5-yr Relative
Survival
Characteristics % (SE) p % (SE) p
Rurality variable 1 0.34 0.47
Rural 12.9 (0.005) 15.2 (0.01)
Urban 11.3 (0.004) 13.4 (0.009)
Rurality variable 2 0.008 0.02
Very rural areas 2.3 (0.02) 2.7 (0.02)
Extended urban areas 12.2 (0.006) 14.4 (0.008)
Gender 0.18 0.36
Male 11.4 (0.007) 13.6 (0.008)
Female 14.8 (0.02) 16.5 (0.02)
Age, yr 103 103
65 15.3 (0.01) 16.3 (0.01)
65 8.3 (0.008) 11 (0.01)
Period of diagnosis 0.15 0.17
1981–1988 10.8 (0.009) 12.7 (0.01)
1989–1996 12.7 (0.009) 15 (0.01)
Histology 103 103
Non-small cell 12.9 (0.007) 15.3 (0.008)
Small cell 6 (0.01) 6.9 (0.01)
Mean annual income 0.01 0.05
85% 8.7 (0.01) 10.3 (0.02)
85% 12.5 (0.007) 14.7 (0.008)
TABLE 3. Multivariate Analyses of Observed and Relative
Survival
Variables Relative Risk (95 % CI) p
Cox model with rurality variable 1
Age 65 yr 1.3 (1.2–1.4) 104
Small cell carcinoma 1.2 (1.1–1.4) 0.003
Rural areas 1 (0.9–1.1) 0.5
Mean annual income 85% 1.1 (1–1.3) 0.03
Period 1989–1996 0.9 (0.9–1) 0.1
Interaction pathology  time 0.7 (0.5–0.9) 0.001
Cox model with the rurality variable 2
Age 65 yr 1.3 (1.2–1.4) 104
Small cell carcinoma 1.2 (1.1–1.4) 0.004
Very rural areas 1.3 (1.02–1.7) 0.03
Mean annual income 85% 1.1 (1–1.2) 0.1
Period 1989–1996 0.9 (0.9–1) 0.1
Interaction pathology  time 0.7 (0.5–0.9) 0.001
Hakulinen and Tenkanen model
Age 65 yr 1.2 (1.1–1.4) 104
Small cell carcinoma 1.4 (1.2–1.5) 104
Very rural areas 1.3 (1.02–1.7) 0.04
Mean annual income 85% 1.1 (1–1.3) 0.1
Period 1989–1996 0.9 (0.9–1) 0.08
CI, confidence interval.
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Proportions of NSCLC stages I and II were 14% in patients
living 58 km or more from the nearest cancer center and 28%
in subjects resident within 5 km (p  0.025). Such urban-
rural differences have also been shown in 3040 lung cancer
cases from the Savannah River Regional Health Information
System Registry between 1991 and 1995.9 Patients living
more than 10 miles from a hospital had a risk of having an
advanced stage of 1.25 (95% CI: 1.0–1.57) when compared
to those living less than 10 miles away (p  0.047). Among
the 5407 lung cancer patients collected by the Georgian
Cancer Registry between 1978 and 1985, the risk of meta-
static disease was compared between residents of metropol-
itan Atlanta and those of 10 neighboring rural counties. It was
1.14 (95% CI: 0.83–1.57) among whites and 1.89 (95% CI:
1.05–3.39) among blacks.8
In France, this geographic variation was studied in
colorectal cancer.22 Of the 1331 new cases collected by the
Calvados Digestive Tract Cancer Registry between 1978 and
1984, patients living in very rural areas, with the same
definition as that used in the present analysis, were 134 for
men and 150 for women. There was no stage difference for
men but 18.8% of women in very rural areas had metastatic
disease and 12.3% of those living in extended urban areas
(p  0.05). Among women, 5-year survival was 30.7% and
40% (p  0.02), respectively. Women living in rural areas
had more severe clinical symptoms. Environment still had a
significant effect after controlling for symptoms and for
disease extension (p  0.05). In a model controlling for
symptoms, disease extension, and age, influence of environ-
ment was of borderline significance (p  0.08). In a multi-
variate analysis adjusting for age, symptoms, type of treat-
ment, and tumor extension, environment no longer had a
significant prognostic effect. These results suggest that dif-
ferences in types of treatment might be another explanation
for the worse prognosis of cancer in rural areas. The results of
another study conducted on 661 new lung cancer cases
collected by the Scottish Cancer Registry in 1995 and 1996
favors the stage hypothesis rather than the treatment differ-
ence explanation, as it showed no difference in treatment with
increasing distance to treatment center or in time between
first referral and treatment.7 This higher proportion of ad-
vanced disease in rural areas could result from a delay in
diagnosis, which may be explained by both practical and
psychological reasons. In a study of 22 colorectal cancer
patients and 10 spouses, Bain and Campbell10 showed that
not only longer distances from specialized centers were a
limitation, but also that poor coordination between primary
and secondary care might be responsible for delayed access to
cancer treatment.10 Psychological profiles were also different
whether patients were living in rural or urban areas. Subjects
living outside the city boundary had lower expectations of
care and were less demanding than their urban counterparts.10
In our study, we also noted that patients living in very rural
areas were less often referred to our hospital (55% versus
68%). Perhaps the distance from all specialized centers (and
not only from the university hospital) along with the differ-
ence in psychological profiles, as reported by Bain and
Campbell, might result in patients from very rural areas,
particularly those with advanced stage disease, not being
referred to specialized centers.
This study showed that the multidimensional definition of
rurality using very rural areas identified lung cancer patients
with a significantly reduced prognosis. Although this population
only accounts for 3.3% of the whole population of the depart-
ment, they cannot be considered as marginal with lung cancer
being a leading cause of cancer deaths in developed countries
and with a survival difference as large as 11.7% at 5 years.
Moreover, it is not acceptable to offer suboptimal care to any
patient, and development of cancer services must take into
account such inequalities to provide uniform quality of care to
all patients wherever they live. Therefore, before adapted sani-
tary measures can be proposed in particular lung cancer care
network reorganization, a subsequent study is ongoing to further
identify areas of worse prognosis and the reasons for poorer
survival, including, performance status, stage, access to cancer
care facilities, and treatment differences.
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